Precigen investor relations material
Listen to the latest call from Precigen
Precigen Inc is an innovator in the discovery and development of next-generation gene and cell therapies, with a mission to enhance the lives of patients through transformational technologies. The company operates in two segments, Precigen, Inc. and Cell Therapy Systems (CTS). The Precigen, Inc. segment discovers and develops the next generation of gene and cellular therapies that address medical needs in cancer, infectious disease and immunological disorders.